Bibliographic Info
GuidelineMental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders, [3rd ed.].
Year of Publication2023
Issuing InstitutionWorld Health Organization
Recommendation
Status
Updated
Recommended in favor
Strong
Certainty of evidence
Moderate
Oral antipsychotic medicines – namely aripiprazole, chlorpromazine, haloperidol, olanzapine, paliperidone, quetiapine, risperidone – should be offered for adults with a psychotic disorder (including schizophrenia), carefully balancing effectiveness, side-effects and individual preference.